Content area

|
|

Udredning og behandling af angst og depression hos patienter med KOL

Forfatter(e)

Ida Stisen Fogh-Andersen1, Ingeborg Farver-Vestergaard2, Christian Møller Pedersen3, Elisabeth Shirin Tehrani4 & Anders Løkke2, 5

1) Operation og Intensiv, Regionshospitalet Randers, 2) Medicinsk Afdeling, Sygehus Lillebælt, Vejle, 3) AS3 Rådgivning, Viby J, 4) Psykiatrisk Afdeling, Aarhus Universitetshospital, 5) Institut for Regional Sundhedsforskning, Det Sundhedsvidenskabelige Fakultet, Syddansk Universitet

Ugeskr Læger 2021;183:V09200679

Reference: 
Ugeskr Læger 2021;183:V09200679
Examination and treatment of anxiety and depression in patients with COPD

Ida Stisen Fogh-Andersen, Ingeborg Farver-Vestergaard, Christian Møller Pedersen, Elisabeth Shirin Tehrani & Anders Løkke

Ugeskr Læger 2021;183:V09200679

An estimated 33% of patients with COPD have co-morbidities in terms of anxiety and/or depression (A&D). A large proportion of these patients are not diagnosed, mainly because some of the core symptoms of A&D can be misinterpreted as being caused by COPD. Untreated A&D in patients with COPD can have a negative impact on several parameters e.g. dyspnoea and mortality. On this basis, this review argues, that special focus in primary care and hospitals on diagnosing and treating A&D in patients with COPD using anti-depressants or cognitive therapy can reduce symptom burden and significantly improve quality of life.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Stefan Svendsen | 30/07
3 kommentarer
af Leo Kirkegaard Winther | 28/07
17 kommentarer
af Ann-Christina Skyttebo Scheffmann | 26/07
1 Kommentar
af Birger Kreutzfeldt | 23/07
10 kommentarer
af Susanne Mejlby Nielsen | 19/07
2 kommentarer
af Toke Seierøe Barfod | 17/07
1 Kommentar
af Betina Damsgaard | 12/07
1 Kommentar
af Preben G. Berthelsen | 12/07
1 Kommentar
af Eskild Boeskov | 11/07
6 kommentarer